More I-O targets mean more shots on goal.

November 5, 2019

New Report Available from ACS: Progress in Global Cancer Fight is not only Possible, but Achievable

October 16, 2019

Breast Cancer Awareness Month begins today and I honor you!

October 1, 2019

Great progress in cancer drug development and approvals but still incredible unmet need.

September 9, 2019

How long should an office visit be? Is 20 minutes enough? Can you call that patient-centric care?

September 3, 2019

Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit

June 21, 2019

Top 20 Drugs of 2018 from Fierce Pharma

June 17, 2019

IQVIA report outlines key 2018 approvals and more

May 31, 2019

IQVIA publishes Global Oncology Trends 2019 just in time for ASCO 2019

May 30, 2019

First Patient Treated Under Right to Try Law

January 11, 2019

Please reload

Recent Posts

New Report Available from ACS: Progress in Global Cancer Fight is not only Possible, but Achievable

October 16, 2019

FDA approves 18 drugs for cancer patients in 2018.

January 9, 2019

More I-O targets mean more shots on goal.

November 5, 2019

1/9

Please reload

Featured Posts

CRI's Comprehensive Analysis of clinical immune-oncology

December 9, 2017

Cancer Research Institute publishes analysis in Annals of Oncology 2017

"Advances in immuno-oncology (IO) are revolutionizing the standard of care for many types of cancer."

"26 immunotherapies have been approved, and 17 types of cancer have at least one approved im- munotherapy as a treatment option."

"It is probably the best time for progress in oncology in the past decades."

Share on Facebook

Share on Twitter

Please reload

Follow Us

Search By Tags

November 2019 (1)

October 2019 (2)

September 2019 (2)

June 2019 (2)